Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$9.49 - $14.26 $94,378 - $141,815
-9,945 Reduced 3.84%
249,000 $2.6 Million
Q1 2024

May 14, 2024

SELL
$12.8 - $16.78 $56,576 - $74,167
-4,420 Reduced 1.68%
258,945 $3.57 Million
Q4 2023

Feb 13, 2024

BUY
$8.89 - $15.36 $74,676 - $129,024
8,400 Added 3.29%
263,365 $3.98 Million
Q3 2023

Nov 13, 2023

SELL
$12.4 - $18.8 $36,518 - $55,366
-2,945 Reduced 1.14%
254,965 $3.31 Million
Q2 2023

Aug 11, 2023

SELL
$14.32 - $18.03 $443,920 - $558,930
-31,000 Reduced 10.73%
257,910 $4.64 Million
Q1 2023

May 12, 2023

SELL
$11.83 - $16.02 $1.63 Million - $2.2 Million
-137,490 Reduced 32.24%
288,910 $4.51 Million
Q4 2022

Feb 13, 2023

BUY
$8.91 - $12.35 $1.79 Million - $2.49 Million
201,400 Added 89.51%
426,400 $5.27 Million
Q3 2022

Nov 10, 2022

BUY
$6.57 - $9.74 $1.48 Million - $2.19 Million
225,000 New
225,000 $1.97 Million

Others Institutions Holding ATEC

About Alphatec Holdings, Inc.


  • Ticker ATEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 104,656,000
  • Market Cap $1.01B
  • Description
  • Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...
More about ATEC
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.